Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2009-05-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Abnormally Fertilized Embryos
NCT06940973
Effects of Day 3 Blastomere Biopsy on Human Embryos
NCT01397487
Embryo Aneuploidies and Ovarian Stimulation
NCT00707525
The Impact of the Biopsy of 1-2 Cells in a PGD Program for Anueploidy Screening
NCT00454311
Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle
NCT02873793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tissue from biopsies
analyse and proliferate the cells
1. Obtention of excess tissue from testicular biopsies and maintained in 4ºC until procedures.
2. Digestion of the biopsies through controlled enzymes
3. Replication of the cells
4. Selection undifferentiated cells
5. Expansion of the purification cells population
6. Characterization of the cell population
7. Assessment of pluripotent and germinal cell potential.
8. Possible maturation of the cells.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
analyse and proliferate the cells
1. Obtention of excess tissue from testicular biopsies and maintained in 4ºC until procedures.
2. Digestion of the biopsies through controlled enzymes
3. Replication of the cells
4. Selection undifferentiated cells
5. Expansion of the purification cells population
6. Characterization of the cell population
7. Assessment of pluripotent and germinal cell potential.
8. Possible maturation of the cells.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Igenomix
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carlos Simon
Principal Investigator; Gynecologist IVI Valencia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos Simon, MDPhD
Role: STUDY_DIRECTOR
IVI Valencia
Marcia Riboldi, PhD
Role: PRINCIPAL_INVESTIGATOR
Fundación IVI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IVI Valencia
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0902-057-F-CS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.